Effects of a pro‐resolving drug in COVID‐19: preclinical studies to a randomized, placebo‐controlled, phase Ib/IIa trial in hospitalized patients. - Almeida, Pedro R. J.; Periard, Alexandre M.; Tana, Fernanda L.; Avila, Renata E.; Milhorato, Larissa B.; Alcantara, Katlen M. M.; Resende, Carolina B.; Serufo, Angela V.; Santos, Felipe R.; Teixeira, Danielle C.; Queiroz‐Junior, Celso M.; Fonseca, Talita C. M.; et al. (British Journal of Pharmacology, 2024)